Scott D. Pegan

2.8k total citations
60 papers, 2.1k citations indexed

About

Scott D. Pegan is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Scott D. Pegan has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 19 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Scott D. Pegan's work include Viral Infections and Vectors (17 papers), interferon and immune responses (12 papers) and Mosquito-borne diseases and control (10 papers). Scott D. Pegan is often cited by papers focused on Viral Infections and Vectors (17 papers), interferon and immune responses (12 papers) and Mosquito-borne diseases and control (10 papers). Scott D. Pegan collaborates with scholars based in United States, Taiwan and Thailand. Scott D. Pegan's co-authors include Andrew D. Mesecar, Éric Bergeron, John V. Dzimianski, Florine E. M. Scholte, Brendan T. Freitas, Courtney M. Daczkowski, Glenn C. Capodagli, Michael E. Johnson, David Crich and Rima Chaudhuri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Scott D. Pegan

60 papers receiving 2.0k citations

Peers

Scott D. Pegan
K.P. Battaile United States
Manoj S. Nair United States
Kiira Ratia United States
Radim Nencka Czechia
Scott D. Pegan
Citations per year, relative to Scott D. Pegan Scott D. Pegan (= 1×) peers Leike Zhang

Countries citing papers authored by Scott D. Pegan

Since Specialization
Citations

This map shows the geographic impact of Scott D. Pegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Pegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Pegan more than expected).

Fields of papers citing papers by Scott D. Pegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Pegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Pegan. The network helps show where Scott D. Pegan may publish in the future.

Co-authorship network of co-authors of Scott D. Pegan

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Pegan. A scholar is included among the top collaborators of Scott D. Pegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Pegan. Scott D. Pegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garrison, Aura R., Vanessa Moresco, Xiankun Zeng, et al.. (2024). Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus. Nature Communications. 15(1). 1722–1722. 8 indexed citations
2.
Wu, Yifei, Scott D. Pegan, David Crich, et al.. (2023). Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening. International Journal of Molecular Sciences. 24(5). 4397–4397. 1 indexed citations
3.
Udompholkul, Parima, et al.. (2023). Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist. Journal of Medicinal Chemistry. 66(12). 8159–8169. 13 indexed citations
4.
Durie, Ian A., et al.. (2021). Structural insights into the interaction of papain-like protease 2 from the alphacoronavirus porcine epidemic diarrhea virus and ubiquitin. Acta Crystallographica Section D Structural Biology. 77(7). 943–953. 5 indexed citations
5.
Bester, S.M., Mark A. Guelta, Jonah Cheung, et al.. (2021). Structural and Biochemical Insights into the Inhibition of Human Acetylcholinesterase by G-Series Nerve Agents and Subsequent Reactivation by HI-6. Chemical Research in Toxicology. 34(3). 804–816. 9 indexed citations
6.
Rice, Christopher A., et al.. (2020). Synthesis, Cytotoxicity, and Genotoxicity of 10-Aza-9-oxakalkitoxin, an N , N , O -Trisubstituted Hydroxylamine Analog, or Hydroxalog, of a Marine Natural Product. Journal of the American Chemical Society. 142(20). 9147–9151. 11 indexed citations
7.
Dzimianski, John V., et al.. (2020). Flipping the substrate preference of Hazara virus ovarian tumour domain protease through structure-based mutagenesis. Acta Crystallographica Section D Structural Biology. 76(11). 1114–1123. 5 indexed citations
8.
Scott, Gary K., Christina Yau, Sophia Mahoney, et al.. (2019). Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition. Molecular Cancer Therapeutics. 18(8). 1374–1385. 37 indexed citations
9.
Dzimianski, John V., et al.. (2019). Structure of interferon-stimulated gene product 15 (ISG15) from the bat species Myotis davidii and the impact of interdomain ISG15 interactions on viral protein engagement. Acta Crystallographica Section D Structural Biology. 75(1). 21–31. 12 indexed citations
10.
Dzimianski, John V., Florine E. M. Scholte, Brendan T. Freitas, et al.. (2019). Determining the molecular drivers of species-specific interferon-stimulated gene product 15 interactions with nairovirus ovarian tumor domain proteases. PLoS ONE. 14(12). e0226415–e0226415. 12 indexed citations
11.
Bester, S.M., Mark A. Guelta, Jonah Cheung, et al.. (2018). Structural Insights of Stereospecific Inhibition of Human Acetylcholinesterase by VX and Subsequent Reactivation by HI-6. Chemical Research in Toxicology. 31(12). 1405–1417. 43 indexed citations
12.
Kim, Sung‐Jin, Omar Awad Alsaidan, Qianjin Li, et al.. (2017). Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression. Cancer Research. 77(24). 6950–6962. 69 indexed citations
13.
Daczkowski, Courtney M., et al.. (2017). Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species. Journal of Molecular Biology. 429(11). 1661–1683. 76 indexed citations
14.
Dzimianski, John V., Courtney M. Daczkowski, Gena Whitney, et al.. (2016). Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species. Journal of Virology. 90(18). 8314–8327. 27 indexed citations
15.
16.
Yang, Ji-Feng, Tamara P. Kondratyuk, Laura E. Marler, et al.. (2010). Isolation and evaluation of kaempferol glycosides from the fern Neocheiropteris palmatopedata. Phytochemistry. 71(5-6). 641–647. 32 indexed citations
17.
Pegan, Scott D., et al.. (2009). A Universal, Fully Automated High Throughput Screening Assay for Pyrophosphate and Phosphate Release from Enzymatic Reactions. Combinatorial Chemistry & High Throughput Screening. 13(1). 27–38. 20 indexed citations
18.
Ratia, Kiira, Scott D. Pegan, Jun Takayama, et al.. (2008). A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proceedings of the National Academy of Sciences. 105(42). 16119–16124. 366 indexed citations
19.
Pegan, Scott D., Héctor Serrano, Christian P. Whitman, & Andrew D. Mesecar. (2008). Structural and mechanistic analysis oftrans-3-chloroacrylic acid dehalogenase activity. Acta Crystallographica Section D Biological Crystallography. 64(12). 1277–1282. 2 indexed citations
20.
Tipparaju, Suresh K., Sara Forrester, Debbie C. Mulhearn, et al.. (2008). Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase. Bioorganic & Medicinal Chemistry Letters. 18(12). 3565–3569. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026